No Picture
Trading Ideas

Exclusive: Chevron workers face demands to reapply for jobs under global restructuring – sources

Chevron Corp employees worldwide are being asked to reapply for positions as part of a cost-cutting program expected to eliminate up to 15% of its workforce, people familiar with the matter said. Employees who are not chosen for jobs should know within weeks, Chief Executive Michael Wirth said in an interview on Monday. Workers not chosen for new assignments would lose their jobs. …read more […]

No Picture
Trading Ideas

NGL Energy Partners Dividend Safety: Will A Recent Cut Save This 20% Yield?

Today, Investment U’s Income Expert, Marc Lichtenfeld, takes a look at NGL Energy Partners’ dividend safety.
It’s been a tough go lately for stocks in the energy sector.
Energy stocks in the S&P 500 have been sliced in half this year. Others, like NGL Energy Partners (NYSE: NGL), have fared even worse. It’s down 64% year to date.
Tulsa, Oklahoma-based NGL is a master limited partnership (MLP) that transports oil and natural gas liquids through its pipelines.
Earlier this year, it slashed its quarterly distribution (MLPs pay distributions, not dividends) from $0.39 to $0.20 per unit (partnerships have units, not shares). But because the …read more […]

No Picture
Trading Ideas

Moderna, Pfizer Have 2-Month Lead Over Coronavirus Vaccine Competitors: Analyst

The coronavirus vaccine race has two likely winners that have surged ahead in a crowded field, according to an SVB Leerink analyst.Pfizer, Moderna In The Lead: It now appears that Moderna Inc (NASDAQ: MRNA) and Pfizer Inc. (NYSE: PFE), along with its German partner BioNTech SE – ADR (NASDAQ: BNTX), have a two month or more advantage over their nearest rivals among coronavirus vaccine developers, SVB Leerink analyst Geoffrey Porges said in a Wednesday note.The conviction comes after Dr. Larry Corey, head of the COVID-19 Prevention Network, shared the development timeline and progress of COVID-19 vaccines developed under the …read more […]

No Picture
Trading Ideas

Carbon Capture Technology Is Ramping Up

I base my beliefs on data, not speculation or hearsay. I’ve done this throughout my entire career.
And that’s why I believe in climate change and its impact on our planet.
I’m not trying to influence your thinking on this subject. But there’s an investment opportunity here.
Climate change’s impacts are generally described as “global warming” or “the greenhouse effect.” These effects manifest as stronger and more frequent hurricanes, uncontrollable wildfires, melting ice caps, rising sea levels, epic flooding and, of course, higher temperatures.
These are all symptoms of an unbalanced planet. Can we get this under control?
Yes, we can.
How Long Have Scientists Known …read more […]

No Picture
Trading Ideas

How to Manage Your Money

This guest post has been written by our friend Melissa Brock over at Benzinga, where you can find reviews for many financial products that could help you secure your financial future. In the following article, Melissa explains all the steps you should be taking to learn how to manage your money. By the time you finish reading, you’ll know exactly what to do.
What’s your response to the phrase “managing your money?”
Does it feel like a massive, overwhelming task? You might feel that way if you’ve never really spent a lot of time organizing your finances.
But managing your money doesn’t …read more […]

No Picture
Trading Ideas

Arm exec says 'firewalls' will protect customer info after Nvidia deal

The $40 billion deal announced last month would reshape the global semiconductor sector because Arm has long acted as a neutral player, supplying intellectual property to Apple Inc , Qualcomm Inc and many others that goes into chips for most of the world’s smart phones and many other kinds of chips. Nvidia has displaced Intel Corp as the biggest U.S. chip company by market capitalization on the strength of its data center chips for artificial intelligence. …read more […]

No Picture
Trading Ideas

Coronavirus Latest: Wednesday, October 7

On Wednesday, Eli Lilly announced that it was applying for FDA emergency use authorization for its coronavirus treatment. This comes as BioNTech and Pfizer start their rolling submission of its coronavirus vaccine to the European Union’s EMA. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus. …read more […]